According to the SEC Form 4 filings, Daly James M, being in a position of
The largest sale of all time was on 2014-02-13 and amounted to 158331 share of Incyte Corporation for $10.53M.
No biography is available at this moment.
| 2024-04-02 | Sale | Madrigal Pharmaceuticals, Inc. MDGL | director | 10,912 0.0548% | $244.51 | $2.67M | -0.18% | |
| 2024-04-01 | Sale | Madrigal Pharmaceuticals, Inc. MDGL | director | 21,577 0.1091% | $257.24 | $5.55M | -4.51% | |
| 2023-08-14 | Sale | Halozyme Therapeutics, Inc. HALO | director | 10,000 0.0076% | $43.74 | $437,410 | -9.31% | |
| 2023-08-11 | Sale | Halozyme Therapeutics, Inc. HALO | director | 10,000 0.0076% | $43.71 | $437,110 | -9.09% | |
| 2020-11-25 | Sale | Halozyme Therapeutics, Inc. HALO | director | 10,363 0.0075% | $40.41 | $418,800 | +2.31% | |
| 2020-08-13 | Sale | Halozyme Therapeutics, Inc. HALO | director | 34,337 0.0247% | $29.12 | $999,893 | +41.83% | |
| 2020-05-11 | Sale | ACADIA Pharmaceuticals Inc. ACAD | director | 26,250 0.0168% | $51.13 | $1.34M | -8.56% | |
| 2019-09-09 | Sale | ACADIA Pharmaceuticals Inc. ACAD | director | 60,000 0.04% | $37.80 | $2.27M | +11.81% | |
| 2015-06-23 | Sale | Incyte Corporation INCY | EVP, Chief Commercial Officer | 22,401 0.0124% | $108.26 | $2.43M | -5.81% | |
| 2015-05-26 | Sale | Incyte Corporation INCY | EVP, Chief Commercial Officer | 23,205 0.0129% | $106.41 | $2.47M | -2% | |
| 2015-04-23 | Sale | Incyte Corporation INCY | EVP, Chief Commercial Officer | 36,941 0.0206% | $107.67 | $3.98M | -1.71% | |
| 2015-02-24 | Sale | Incyte Corporation INCY | EVP, Chief Commercial Officer | 16,668 0.0098% | $81.77 | $1.36M | +30.84% | |
| 2015-02-23 | Sale | Incyte Corporation INCY | EVP, Chief Commercial Officer | 5,556 0.002% | $50.88 | $282,689 | +27.32% | |
| 2015-01-23 | Sale | Incyte Corporation INCY | EVP, Chief Commercial Officer | 22,218 0.0126% | $77.68 | $1.73M | +32.98% | |
| 2014-12-23 | Sale | Incyte Corporation INCY | EVP, Chief Commercial Officer | 22,226 0.0142% | $74.43 | $1.65M | +52.18% | |
| 2014-11-24 | Sale | Incyte Corporation INCY | EVP, Chief Commercial Officer | 22,222 0.013% | $74.08 | $1.65M | +37.95% | |
| 2014-10-23 | Sale | Incyte Corporation INCY | EVP, Chief Commercial Officer | 11,111 0.0064% | $53.49 | $594,327 | +83.22% | |
| 2014-09-23 | Sale | Incyte Corporation INCY | EVP, Chief Commercial Officer | 11,111 0.0066% | $47.65 | $529,439 | +93.42% | |
| 2014-08-25 | Sale | Incyte Corporation INCY | EVP, Chief Commercial Officer | 11,111 0.0064% | $51.96 | $577,328 | +60.58% | |
| 2014-07-23 | Sale | Incyte Corporation INCY | EVP, Chief Commercial Officer | 11,111 0.0065% | $48.54 | $539,328 | +55.82% |